Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Advaxis encouraged by new cancer-fighting drug data as the company gears up for clinical trials

% of readers think this story is Fact. Add your two cents.


Advaxis Inc (NASDAQ:ADXS) is encouraged by favorable data from its new cancer immunotherapy treatment that demonstrated tumor-fighting properties, it said in a note Monday.

The Princeton, New Jersey-based company is focused on the discovery, development and commercialization of treatments that boosts the body’s natural defenses to fight cancer.

Phase 1 clinical trials are about to begin on its primary neoantigen, or tumor-directed therapy, ADXS-NEO. In preliminary data, the treatment demonstrated anti-tumor immune activation within one week after the first dose.

READ: ImmunoPrecise signs up a slew of new pharma clients for its antibody-discovering phage display platform

CEO Kenneth Berlin said in a statement that the results fuel Advaxis’s belief that neoantigen-directed immunotherapies can become an important addition to the cancer treatment paradigm due to the unique presentation of neoantigens in cancer cells.

“The results from our ADXS-NEO program have shown the ability to have an impact within the tumor microenvironment in metastatic colorectal cancer, which historically has been a tumor type that is refractory to immunotherapy,” he said. “We look forward to starting Part B of the study with ADXS-NEO in combination with a checkpoint inhibitor in the third quarter of this year.”

During fiscal 2Q ending April 30, 2019, the biotechnology company reported total revenue of $1.2 million compared to the $1.7 million in 2Q 2018. Advaxis said the decrease was due to the termination of a collaboration with biopharmaceutical company Amgen.

Net loss for the second quarter of 2Q 2019 was $9.4 million or $1.59 per share, compared with a loss of $13.4 million or $4.03 per share during the year-ago quarter.

The company said it is in discussions with a leading academic institution to finalize an investigator-sponsored trial evaluating ADXS-HOT in patients with prostate cancer and anticipate filing an Investigational New Drug application with the US Food and Drug Administration later this year.

Shares of Advanxis lost 10.7% in aftermarket trading to sit at $2.50.

Contact Angela at angela@proactiveinvestors.com

Follow her on Twitter @AHarmantas

Story by ProactiveInvestors


Source: https://www.proactiveinvestors.com/companies/news/221821/advaxis-encouraged-by-new-cancer-fighting-drug-data-as-the-company-gears-up-for-clinical-trials-221821.html


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Lion’s Mane Mushroom

Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, But it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes:

Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity.

Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins.

Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system.

Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome.

Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function.

Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules. Today Be 100% Satisfied Or Receive A Full Money Back Guarantee Order Yours Today By Following This Link.

Report abuse

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login

    Newsletter

    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.